About Sonara
Sonara began with a simple but urgent belief: methadone treatment should be easier to access without compromising the structure that keeps patients safe.
The idea took shape while our CEO, Dr. Michael Giles, was completing his psychiatry training. During that time, he worked closely with an opioid treatment program (OTP) and saw firsthand both the dedication of care teams and the barriers patients face in staying engaged with treatment. Daily clinic visits, transportation challenges, work conflicts, parental obligations, and stigma often stood between patients and the stability they were working toward.
Those experiences pointed to a broader need: providers needed better visibility into what was happening between clinic visits, including at-home adherence, cravings, withdrawal, and overall mental well-being, so they could expand access more confidently and deliver treatment more effectively.
Sonara partners with OTPs to expand access while maintaining clinical oversight and compliance. Through our Hybrid Care Model, patients can take medication at home while remaining securely connected to their care teams.
We believe fewer lives would be lost to opioid dependency if treatment barriers were eliminated. By blending in-person care with accountable remote tools, we’re helping treatment work in the real world.
More flexibility. More trust. Improved outcomes.
We're proud to announce that Sonara was named one of America’s Greatest Startup Workplaces 2026
Crafted with kindness and curiosity.
Sonara exists to remove treatment barriers so that people with opioid dependency can live the life they desire.
Modern Framework
Fewer in-person visits makes treatment more convenient and efficient.
Environment of Trust
When treatment doesn’t interfere with their daily lives, patients are more likely to stay the course.
Better Outcomes
With clearer insights into patients' take-home journeys, clinicians can feel confident in making informed treatment decisions.
Learn about Sonara and the work we do.
Get in touch.
Please reach out with any media inquiries.
